STING1 and precursor B-cell acute lymphoblastic leukemia: Expression levels of TMEM173 were increased in granulocytes, progenitor cells, mast cells, and plasmacytoid dendritic cells (pDCs), especially in the BM of B-ALL patients (Fig. 1D, E).